Last reviewed · How we verify
Intradermal HBV 1 course
At a glance
| Generic name | Intradermal HBV 1 course |
|---|---|
| Sponsor | The HIV Netherlands Australia Thailand Research Collaboration |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Hepatitis B Vaccination (HBV) in HIV Infected Children (PHASE2)
- Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: